Dr Sam Moxon narrates his blog written for Dementia Researcher.
You develop something genuinely different, cost it, build the team, submit it feeling confident, and then the rejection lands. In this blog, Dr Sam Moxon sits with the researchers who keep watching their most original ideas fall at the panel while safer, more familiar work sails through. He asks a question the field tends to avoid: are our funders too risk averse to back the ideas that might actually change things, and what does that caution do to the people early in their careers who cannot afford to fail?
Dr Sam Moxon is a biomaterials Research Fellow at University of Birmingham. His expertise falls on the interface between biology and engineering. His PhD focussed on regenerative medicine and he now works on trying to develop 3D bioprinting techniques with human stem cells, so that we better understand and treat degenerative diseases. He is also the Founder and CEO of Aegis FibreTech. Outside of the lab he hikes through the Lake District and is an expert on all things Disney.
This podcast is brought to you by University College London in association with the National Institute for Health and Care Research, Alzheimer's Association, Alzheimer's Research UK, Alzheimer's Society and Race Against Dementia, who we thank for their ongoing support.
Podden och tillhörande omslagsbild på den här sidan tillhör
Dementia Researcher. Innehållet i podden är skapat av Dementia Researcher och inte av,
eller tillsammans med, Poddtoppen.
